UBS raised the firm’s price target on Exponent (EXPO) to $81 from $76 and keeps a Neutral rating on the shares. Recent investor meetings left a positive impression, with management signaling a return to FTE growth that should support a stronger revenue trajectory in 2026, the analyst says in a research note. Improving demand, particularly in Consumer Electronics, and Exponent’s premium, highly technical positioning suggest accelerating financial momentum into 2026 despite lingering investor concerns, UBS says.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXPO:
- Exponent upgraded to Outperform from Market Perform at William Blair
- Exponent price target lowered to $90 from $100 at Truist
- Exponent’s Earnings Call: Revenue Growth Amid Challenges
- Exponent Reports Strong Q3 2025 Financial Results
- Cautious Hold on Exponent Amid Strong Q3 Performance and Mixed Segment Growth